Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95


Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats.

Nemeth CL, Paine TA, Rittiner JE, Béguin C, Carroll FI, Roth BL, Cohen BM, Carlezon WA Jr.

Psychopharmacology (Berl). 2010 Jun;210(2):263-74. doi: 10.1007/s00213-010-1834-7. Epub 2010 Apr 1.


Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats.

Chartoff EH, Potter D, Damez-Werno D, Cohen BM, Carlezon WA Jr.

Neuropsychopharmacology. 2008 Oct;33(11):2676-87. doi: 10.1038/sj.npp.1301659. Epub 2008 Jan 9.


Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.

Potter DN, Damez-Werno D, Carlezon WA Jr, Cohen BM, Chartoff EH.

Biol Psychiatry. 2011 Oct 15;70(8):744-53. doi: 10.1016/j.biopsych.2011.05.021. Epub 2011 Jul 14.


Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens.

Ebner SR, Roitman MF, Potter DN, Rachlin AB, Chartoff EH.

Psychopharmacology (Berl). 2010 Jun;210(2):241-52. doi: 10.1007/s00213-010-1836-5. Epub 2010 Apr 7.


N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.

Béguin C, Potter DN, Dinieri JA, Munro TA, Richards MR, Paine TA, Berry L, Zhao Z, Roth BL, Xu W, Liu-Chen LY, Carlezon WA Jr, Cohen BM.

J Pharmacol Exp Ther. 2008 Jan;324(1):188-95. Epub 2007 Oct 19.


Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTic.

Van't Veer A, Yano JM, Carroll FI, Cohen BM, Carlezon WA Jr.

Neuropsychopharmacology. 2012 Dec;37(13):2809-16. doi: 10.1038/npp.2012.151. Epub 2012 Sep 5.


Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.

Carlezon WA Jr, Béguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM.

J Pharmacol Exp Ther. 2006 Jan;316(1):440-7. Epub 2005 Oct 13.


The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.

Tejeda HA, Chefer VI, Zapata A, Shippenberg TS.

Psychopharmacology (Berl). 2010 Jun;210(2):231-40. doi: 10.1007/s00213-010-1799-6. Epub 2010 Mar 16.


Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.

Placzek MS, Van de Bittner GC, Wey HY, Lukas SE, Hooker JM.

Neuropsychopharmacology. 2015 Dec;40(13):2865-72. doi: 10.1038/npp.2015.159. Epub 2015 Jun 10.


Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats.

Killinger BA, Peet MM, Baker LE.

Pharmacol Biochem Behav. 2010 Sep;96(3):260-5. doi: 10.1016/j.pbb.2010.05.014. Epub 2010 May 20.


The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats.

Nikiforuk A, Popik P.

Eur Neuropsychopharmacol. 2014 Aug;24(8):1381-93. doi: 10.1016/j.euroneuro.2014.04.007. Epub 2014 May 4.


Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.

Braida D, Capurro V, Zani A, Rubino T, Viganò D, Parolaro D, Sala M.

Br J Pharmacol. 2009 Jul;157(5):844-53. doi: 10.1111/j.1476-5381.2009.00230.x. Epub 2009 May 5.


Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats.

Paine TA, Tomasiewicz HC, Zhang K, Carlezon WA Jr.

Biol Psychiatry. 2007 Sep 15;62(6):687-93. Epub 2007 Mar 7.


The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.

Butelman ER, Rus S, Prisinzano TE, Kreek MJ.

Psychopharmacology (Berl). 2010 Jun;210(2):253-62. doi: 10.1007/s00213-009-1771-5. Epub 2010 Jan 19.


A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory.

Smith JW, Gastambide F, Gilmour G, Dix S, Foss J, Lloyd K, Malik N, Tricklebank M.

Psychopharmacology (Berl). 2011 Sep;217(2):255-69. doi: 10.1007/s00213-011-2277-5. Epub 2011 Apr 12.


Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.

Walentiny DM, Vann RE, Warner JA, King LS, Seltzman HH, Navarro HA, Twine CE Jr, Thomas BF, Gilliam AF, Gilmour BP, Carroll FI, Wiley JL.

Psychopharmacology (Berl). 2010 Jun;210(2):275-84. doi: 10.1007/s00213-010-1827-6. Epub 2010 Mar 31.


The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.

Butelman ER, Harris TJ, Kreek MJ.

Psychopharmacology (Berl). 2004 Mar;172(2):220-4. Epub 2003 Oct 30.


Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats.

Xin J, Zhang Y, He Z, Wang Z.

Brain Res. 2016 Apr 15;1637:168-76. doi: 10.1016/j.brainres.2016.02.024. Epub 2016 Feb 21.


Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia.

Harden MT, Smith SE, Niehoff JA, McCurdy CR, Taylor GT.

Behav Pharmacol. 2012 Oct;23(7):710-5. doi: 10.1097/FBP.0b013e3283586189.


Supplemental Content

Support Center